BSE filing, NSE: FAZE3Q. Summary written from the filing by ALFA Finder's alert engine.
Faze Three Ltd: key numbers
- Share price
- ₹561.50
- Market cap
- ₹1,381 Cr
- Revenue (annual)
- ₹923.1 Cr
- Net profit (annual)
- ₹33.57 Cr
- P/E (TTM)
- 27.0×Sector 34.2×
- Promoter holding
- 57.35%-0.66% QoQ
- FII holding
- 0.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Faze Three Ltd
All →Faze Three Investor Presentation: Key Takeaways
Q2 FY27 total income INR 267.8 Cr (+29.1% YoY), EBITDA margin 13.29%, PAT INR 15.5 Cr; H1 revenue +18.9%. Capex cycle ends FY27; China+1 demand tailwind cited.
- Call
- Guides 20% growth
Faze Three Q2 FY27 Results: Turns Profitable, Net Profit ₹15.5 Cr
Faze Three reported standalone unaudited results for the quarter ended 30 September 2026. Revenue from operations was Rs.247.34 Crore, with profit for the period of Rs.11.74 Crore.
- Key figure
- Net profit ₹15.5 Cr
Faze Three Board Meeting Date
Faze Three Ltd intimated a board meeting on November 3, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closure is also noted.
Faze Three Other Announcement
Faze Three Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, including an explanatory note regarding ESOP Trust shareholding adjustments.
Faze Three Business Update
Faze Three Limited informed the exchange about an interview of its President, Vishnu Anand, published in Dun & Bradstreet's 'Business Enterprises of Tomorrow' report.
Faze Three Management Change
Faze Three Limited has appointed Mr. Mohit Dinesh Solanki as an Independent Director for a five-year term effective August 17, 2026. The appointment was approved at the AGM.
Other other announcement announcements
All →Brand Concepts Other Announcement
Brand Concepts Limited reported zero deviation in the utilization of funds raised through convertible warrants for the quarter ended September 2026. The company utilized the entire raised amount of Rs. 14.75 Crore for working capital and business expansion.
Mankind Pharma Other Announcement
Mankind Pharma Limited received an ESG rating of 64.8 from SES ESG Research. This rating was independently assigned for FY26 based on publicly available information.
Moneyview Other Announcement
Moneyview Ltd has appointed Ankit Kumar Jain as Nodal Officer for the Investor Education and Protection Fund. This role handles claim verification and coordination with the IEPF Authority.
Mastek Other Announcement
Mastek Limited has announced a change in the corporate office address of its Registrar and Share Transfer Agent, KFin Technologies Limited. The change is effective December 1, 2026.
Desi Farms India Other Announcement
Desi Farms India Ltd has appointed M/s Ojha Agrawal & Associates as Statutory Auditors. The appointment fills a casual vacancy following the resignation of the previous auditors.
Citurgia Biochemicals Other Announcement
Citurgia Biochemicals Limited received approval from the Registrar of Companies to extend its 51st Annual General Meeting deadline. The meeting will now be held by December 31, 2026.